BK-600 (Anti-IL-4Rα mAb)

About Sichuan Biokin Pharmaceutical

Sichuan Biokin Pharmaceutical's mission is to develop and commercialize high-quality, accessible biologic medicines for patients in China and worldwide. The company has achieved significant success by establishing itself as a dominant player in the Chinese biologics market, evidenced by its substantial market capitalization and integrated capabilities from discovery through commercialization. Its core strategy employs a dual-track approach: generating stable cash flow from biosimilars to fund the research and development of novel therapeutic antibodies in high-value therapeutic areas.

Therapeutic Areas

Other Atopic Dermatitis, Asthma Drugs